Shijiazhuang Yiling Pharmaceutical Management
Management criteria checks 3/4
Shijiazhuang Yiling Pharmaceutical's CEO is Xiang Jun Wu, appointed in Apr 2013, has a tenure of 12.08 years. directly owns 5.2% of the company’s shares, worth CN¥1.28B. The average tenure of the management team and the board of directors is 11.1 years and 7.7 years respectively.
Key information
Xiang Jun Wu
Chief executive officer
CN¥3.0m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 12.1yrs |
| CEO ownership | 5.2% |
| Management average tenure | 11.1yrs |
| Board average tenure | 7.7yrs |
Recent management updates
Recent updates
CEO
Xiang Jun Wu (49 yo)
Mr. Xiang Jun Wu has been General Manager at Shijiazhuang Yiling Pharmaceutical Co., Ltd. since April 2013 and also has been its Chairman since February 27, 2023 and Director since August 31, 2010 and serv...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 12.1yrs | CN¥3.00m | 5.2% CN¥ 1.3b | |
| CFO & Director | 7.1yrs | CN¥1.74m | no data | |
| Deputy GM & Director of Administrative Center | 14.3yrs | CN¥840.00k | 0.12% CN¥ 29.6m | |
| Deputy General Manager & General Manager of the Marketing | no data | CN¥1.49m | no data | |
| Executive Deputy Director of the Human Resources Center & Director | no data | CN¥840.00k | 0.017% CN¥ 4.2m | |
| Secretary of the Board & Non-Independent Director | 14.8yrs | CN¥1.89m | 0.59% CN¥ 144.0m | |
| Deputy GM & Non-Independent Director | 10.2yrs | CN¥1.88m | 0.017% CN¥ 4.2m | |
| Deputy GM & Director of the Supply Center | 2.3yrs | CN¥1.17m | 0.032% CN¥ 7.8m | |
| Accounting Supervisor | no data | no data | no data | |
| Supervisor & Director of the Logistics Department of the Administrative Center | no data | no data | 0.00065% CN¥ 160.0k |
Experienced Management: 002603's management team is seasoned and experienced (11.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 14.8yrs | CN¥3.00m | 5.2% CN¥ 1.3b | |
| CFO & Director | 7yrs | CN¥1.74m | no data | |
| Executive Deputy Director of the Human Resources Center & Director | 5.3yrs | CN¥840.00k | 0.017% CN¥ 4.2m | |
| Secretary of the Board & Non-Independent Director | 8.4yrs | CN¥1.89m | 0.59% CN¥ 144.0m | |
| Deputy GM & Non-Independent Director | 5.3yrs | CN¥1.88m | 0.017% CN¥ 4.2m | |
| Supervisor & Director of the Logistics Department of the Administrative Center | 10.8yrs | no data | 0.00065% CN¥ 160.0k | |
| Chairman of the Supervisory Board | 10.8yrs | no data | 0.074% CN¥ 18.3m | |
| Director | 12.1yrs | CN¥840.00k | 0.037% CN¥ 9.1m | |
| Employee Representative Supervisor | 14.8yrs | no data | no data | |
| Independent Director | 5.3yrs | CN¥120.00k | no data | |
| Independent Director | 2.3yrs | CN¥120.00k | no data | |
| Independent Director | less than a year | CN¥60.00k | no data |
Experienced Board: 002603's board of directors are considered experienced (7.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/23 07:18 |
| End of Day Share Price | 2025/05/23 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shijiazhuang Yiling Pharmaceutical Co., Ltd. is covered by 14 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Weiying Tu | China International Capital Corporation Limited |
| Diandian Li | China Merchants Securities Co. Ltd. |